Quantum Biopharma Ltd QNTM

$1.94 -0.08 (-3.96%)

Valuation

Market cap
18,035,000
Revenue TTM
$0
Net income TTM
$-26,180,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
144,500
Avg volume
153,780
Day's range
$1.91 – $2.13
Shares out
8,087,000
Stochastic %K
4%
Beta
0.51
Analysts
Strong Buy
Price target
$21.75

Price

Company profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de...

Show more

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
833-304-0323
Website
https://www.quantumbiopharma.com
Address
1 Adelaide Street East, Suite 801, Toronto, Canada

Latest news

Stocktwits

SirTrollalot Nov 11, 11:25 PM
$QNTM damn
0 replies
NetworkNewsWire Nov 11, 7:24 PM
BioMedNewsBreaks – $QNTM Reports Shareholder Meeting Results, Closes Private Placement Increasing Insider Voting Control https://ibn.fm/jperB
0 replies
sunnycorax Nov 11, 7:00 PM
Kevin Malone's lawyer dropped him because he completely ghosted his lawyer, refused to comply with the Idaho DOF subpoena, and hasn't paid his lawyer. BTW failure to comply is grounds for contempt. He hasn't received any communication from Malone since September. $GNS $QNTM https://youtube.com/live/BPvZsfkgzcc
1 replies
d12345678982 Nov 11, 2:19 PM
$QNTM $GNS $GME $NWBO
0 replies
FickleFin Nov 11, 2:17 PM
$QNTM $GNS so Roger is HIDING after reverse split announcement. 🤡 $QNTM just announced the approval of share structure, name change, and Reverse Split... AGAIN. 🖕🖕🖕 Market Cap keeps dropping. Voting leverage was 58% now 67%. They control everything. Theyre fucking over retail just like ROGER. QNTM Saeed and Anthony are just siphoning $$ into their xorax trust/fortius trust account.$GME $NWBO
0 replies
focafoca99 Nov 11, 12:24 PM
$QNTM closed a private placement of 26 Class A Multiple Voting Shares, raising C$80.86 million.
1 replies
Gentleman4599 Nov 11, 4:43 AM
$QNTM I see above How do you feel about QNTM? My Answer is : Disaster, Utterpolp, Worst, Keep your Money safe, Show your Sales, Dangerous to your Financieals , Personals. Do you need more answers ?
0 replies
Gentleman4599 Nov 11, 4:27 AM
$QNTM Dear Friends, Respect @Fickelfin. His posts are 100% true. This is most pump and dump. They closed their cinema in Can stock exchange and playing here. So far no trustable products. I lost my Money here.
0 replies